On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Dalhousie’s Dr. Christine Chambers and her colleagues at Solutions for Kids in Pain (SKIP) are working with hospitals to ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...